Order Article Reprints

Zhao B-W, Zhang F-Y, Wang Y, Chen G-M, Nie M, Zhao Z-K, Chen X-J, Jiang K-M, Nie R-C, Chen Y-B. LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials. Cancers. 2022; 14(20):4975. https://doi.org/10.3390/cancers14204975

Zhao, Bai-Wei, Fei-Yang Zhang, Yun Wang, Guo-Ming Chen, Man Nie, Zhou-Kai Zhao, Xiao-Jiang Chen, Kai-Ming Jiang, Run-Cong Nie, and Ying-Bo Chen. 2022. "LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials" Cancers 14, no. 20: 4975. https://doi.org/10.3390/cancers14204975

Zhao, B.-W., Zhang, F.-Y., Wang, Y., Chen, G.-M., Nie, M., Zhao, Z.-K., Chen, X.-J., Jiang, K.-M., Nie, R.-C., & Chen, Y.-B. (2022). LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials. Cancers, 14(20), 4975. https://doi.org/10.3390/cancers14204975